COMPANY
Mabwell (Shanghai) Bioscience Co., Ltd.
Sourced facts
- Antibody-drug conjugate program bulumtatug fuvedotin: ClinicalTrials.gov lead sponsor (1 trial) · clinicaltrials.gov/study/NCT06908928 · checked Oct 20, 2026
- “Mabwell (688062.SH, 02493.HK) is an innovation-driven biopharmaceutical company” · www.mabwell.com · checked Oct 20, 2026
- China-based company (HQ: Shanghai, China, per the HQ source above).